Showing results (741-750 of 2,609) with videos related to
Sort By:
Pageof 261
Oncology Research|January 1, 1997
Pure antiestrogens as a new therapy for breast cancerG M England, V C JordanOncology Research|January 1, 1997
Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cellsU Vanhoefer, W Voigt, R A Hilger, et al.Oncology Research|December 3, 2003
Epidermal growth factor-responsive laryngeal squamous cancer cell line Hep2 is more sensitive than unresponsive CO-K3 one to quercetin and tamoxifen apoptotic effectsG Raspaglio, G Ferrandina, C Ferlini, et al.Oncology Research|October 14, 2003
Reductive metabolism of the nitroimidazole-based hypoxia-selective cytotoxin NLCQ-1 (NSC 709257)Maria V Papadopoulou, Ming Ji, Mira K Rao, et al.Oncology Research|October 14, 2003
Increased activity and expression of phospholipase D2 in human colorectal cancerHirokazu Oshimoto, Shinichi Okamura, Makoto Yoshida, et al.Oncology Research|October 14, 2003
Development of a syngeneic in vivo tumor model and its use in evaluating a novel P-glycoprotein modulator, PGP-4008Brian D Lee, Kevin J French, Yan Zhuang, et al.Oncology Research|January 1, 1992
Characterization of insulin-like growth factor receptors in the insulin-responsive R3230AC mammary adenocarcinomaB Korc-Grodzicki, R W Furlanetto, R HilfOncology Research|January 1, 1992
Selective formation of tumor necrosis factor-alpha (TNF) degradation products contributes to TNF mediated cytotoxicityJ P Fruehauf, B K SinhaPageof 261